- Execution rate: 1 share - 1 voting right
- Planned Meeting time: 24/04/2026.
- Meeting venue: to be announced in the invitation letter
- Tentative Meeting agenda:
+ 2021 - 2025 period  activity report by the Board of Directors (BOD);
+ 2021 - 2025 period activity report by the Internal Audit Committee;
+ 2025 activity summary report by the Management Board;
+ 2026 production and business plan;
+ Other related issues within the authority of the General meeting
Coordination details and procedures for corporate action processing for holders of the above securities between VSDC, the Securities registering institution and depository members are specified in the Guideline on corporate action processing for securities holders at VSDC.
Nha Trang Vaccines And Biological Products Joint-Stock Company  and the parties involved in the process of preparing the dossier, documents of corporate action processin are fully responsible before the law for the legality, accuracy, truthfulness and completeness of the dossier; Institutions and individuals participating in the confirmation of records and documents shall be legally responsible within the scope related to such records and documents as prescribed in Clause 1, Article 11a of the Securities Law No. 54/2019/QH14 dated 26/11/2019, supplemented by Clause 4, Article 1 of Law No. 56/2024/QH15 dated 29/11/2024.